Subcutaneous may offer slightly more consistent plasma levels, but the practical difference is marginal given the compounds short half-life requiring daily dosing either way
Full-length trial data does not transfer to the TB-500 fragment, so verify vial identity
MIC B12 injections are not a standalone solution for significant weight loss
Acknowledgments The writing of the manuscript was assisted by ChatGPT (OpenAI, California, US) and Grammarly (Superhuman Platform Inc., California, US) for language support
This article examines the evidence, appropriate clinical indications, potential risks, and NHS guidance on B12 treatment and weight management
Ontario Health Technology Assessment Series 2013;13:124